Mechanistic Pathways · 9 min read · 2027-10-28
Spirulina and MAIT Cells
A T-cell population that recognizes vitamin B2 metabolites instead of peptides. They guard mucosal surfaces against pathogens that use the riboflavin biosynthesis pathway.
MAIT Cell Biology
Mucosal-associated invariant T (MAIT) cells express semi-invariant TCR (Vα7.2-Jα33 in humans) recognizing riboflavin-derivative antigens presented on MR1 (MHC-class-I-related molecule). Specifically, 5-OP-RU (a riboflavin biosynthesis intermediate) is the most potent activator. Bacteria and yeasts that synthesize riboflavin generate MAIT antigens; viruses don't.
Mucosal Localization
MAIT cells comprise ~10% of liver T cells, ~3-5% of circulating, and abundant in mucosal tissues. They produce IFN-γ, TNF-α, IL-17, and granzyme rapidly upon activation. MAIT decline in obesity, T2D, and aging contributes to impaired mucosal immunity. Spirulina's reduced inflammation preserves MAIT populations.
Riboflavin Substrate
Spirulina contains substantial riboflavin (~3.5 mg/100g). Microbial conversion of riboflavin produces MR1 ligands activating MAIT cells. Spirulina's microbiota enrichment of Lactobacillus and Bifidobacterium (riboflavin-metabolizing bacteria) supports MAIT antigen production at mucosal surfaces.
Conclusion
Spirulina supports MAIT cell function through preserved MAIT populations under inflammation, riboflavin substrate provision, and microbial riboflavin metabolism enhancement. Clinical relevance to mucosal immunity, infection susceptibility, and inflammatory bowel disease. MAIT cells are a relatively underrecognized component of mucosal defense — spirulina engages multiple supporting mechanisms.